GlassScriptPhysician profile
Tushar P Dandade
NPI 1477647840
$22,606.38
in general payments reported to CMS, 2019-2025
14 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,498 · 2020: $4,719 · 2021: $8,684 · 2022: $175 · 2023: $152 · 2024: $229 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,783.24 | 2019-2025 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $139.96 | 2022-2023 | Acessa Provu System |
| Astellas Pharma US INC | $108.70 | 2019-2025 | Veozah |
| Coloplast Corp | $99.31 | 2020-2022 | |
| Abbvie INC. | $97.28 | 2019-2020 | |
| Organon LLC | $89.47 | 2025 | Jada System |
| Medtronic, INC. | $72.81 | 2024 | Interstim |
| Caldera Medical, INC | $49.40 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.07 | 2019-2020 | |
| Applied Medical Resources Corporation | $37.19 | 2024 | |
| Coopersurgical, INC. | $29.95 | 2019-2024 | Paragard T 380a |
| Boston Scientific Corporation | $23.69 | 2024 | Solyx Sis System |
| Avanos Medical | $13.87 | 2019 | |
| Merck Sharp & Dohme LLC | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tushar Dandade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.